Contact
Please use this form to send email to PR contact of this press release:
Paras Biopharma Announces Industry leading Scale-up Development & Production Process of an "Onco-Immunology Fc-fusion"
TO:
Mark Jackson
Paras Biopharmaceuticals Finland Oy
+358 44 2905993